Speaking at the event, the Exchange's Head of European Business Development, Charlotte Crosswell, said: "The Nordic region is highly respected for its innovation and expertise in the biotechnology and healthcare industries. We have a lot to offer companies in this sector."
The Exchange has recently launched the world's first market for healthcare companies, techMARK mediscience. It also operates AIM, the global market for smaller growing companies from all sectors.
Charlotte Crosswell went on to explain: "Nordic healthcare companies with international ambitions should consider a London listing as a serious option. No other exchange in the world can offer the same level of service to this type of company. We give access to a massive pool of international capital and offer global visibility for companies on our markets."
techMARK mediscience is designed for healthcare companies of all sizes. The market and its indexes provide a focal point for international investors who are interested in this specialised sector. The entry requirements are the same as for the main market in London and include special exemptions for healthcare companies without a three-year trading history.
AIM has less stringent entry requirements and is designed especially for smaller growing companies. It is open to healthcare companies as well as companies from other industries. AIM has been very successful since its launch it 1995 and in 2001 it attracted 94 IPOs - almost 40 per cent of IPOs in western Europe for the
